Clinical Trials Directory

Trials / Completed

CompletedNCT05312528

Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis

Diagnostic Value of Annexin V, sVCAM-1, sICAM-1, Vascular Endothelial Growth Factor, TNF Alpha and Interleukin-6 in Ovarian and Deep Infiltrating Endometriosis, the Changes of These Markers in the Postoperative Period

Status
Completed
Phase
Study type
Observational
Enrollment
79 (actual)
Sponsor
Bagcilar Training and Research Hospital · Other Government
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The diagnostic value of Annexin V, sVCAM-1, sICAM-1, vascular endothelial growth factor and Proinflammatory cytokines (TNF-a and interleukin-6) in ovarian endometriosis and deep infiltrating endometriosis, their levels in organ-specific involvement, their relationship with symptoms, and the changes of these markers in the postoperative period will be evaluated.

Detailed description

Serum Annexin V, sVCAM-1, sICAM-1, vascular endothelial growth factor and proinflammatory cytokines (TNF-a and interleukin-6) values were studied by taking blood samples from all patients before and three months after the operation.

Conditions

Interventions

TypeNameDescription
PROCEDUREendometriosis surgeryLaparoscopy was performed in the follicular phase of the woman's menstrual cycle and all recognizable endometriotic lesions were treated by bipolar coagulation, resection of endometriotic nodules and ovarian cystectomy.
PROCEDUREother benign condition surgeriesovarian cystectomy, bilateral tubal ligation, myomectomy etc.

Timeline

Start date
2018-02-01
Primary completion
2019-02-01
Completion
2019-03-01
First posted
2022-04-05
Last updated
2022-04-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05312528. Inclusion in this directory is not an endorsement.